Genprex (GNPX) Expected to Announce Earnings on Monday

Genprex (NASDAQ:GNPX) will likely be issuing its quarterly earnings data before the market opens on Monday, April 7th. Analysts expect the company to announce earnings of ($0.39) per share for the quarter.

Genprex Stock Down 21.1 %

Shares of GNPX stock opened at $0.27 on Monday. Genprex has a 12 month low of $0.25 and a 12 month high of $4.09. The company has a 50 day simple moving average of $0.45 and a two-hundred day simple moving average of $0.82.

Genprex Company Profile

Genprex, Inc, a clinical-stage gene therapy company, focuses on developing gene-based therapies for patients with cancer and diabetes in the United States. The company's lead product candidate is REQORSA (GPX-001), which is in preclinical trials to treat non-small cell lung cancer and small cell lung cancer; and GPX-002, which is in preclinical trials to treat type 1 and type 2 diabetes.